Skip to main content
Premium Trial:

Request an Annual Quote

Aclara BioSciences to Add R&D Systems Reagents to eTag Assay

NEW YORK, May 21 - Aclara BioSciences of Mountain View, Calif., today said it has signed an agreement to add reagents supplied by Research and Diagnostic Systems of Minneapolis for sale with its eTag assay system.

 

In a non-exclusive agreement, R&D Systems, a subsidiary of Techne Corp., will supply Aclara with cytokines and related proteins and antibodies that will be marketed as part of the eTag assay system. Financial details were not disclosed.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.